|
|
Volumn 19, Issue 3, 2001, Pages 184-185
|
|
Biotech industry faces new bottleneck
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MONOCLONAL ANTIBODY;
ARTICLE;
BIOSYNTHESIS;
BIOTECHNOLOGY;
CONSTRUCTION WORK AND ARCHITECTURAL PHENOMENA;
DRUG INDUSTRY;
ECONOMICS;
ORGANIZATION AND MANAGEMENT;
TIME;
UNITED STATES;
ANTIBODIES, MONOCLONAL;
BIOTECHNOLOGY;
DRUG INDUSTRY;
FACILITY DESIGN AND CONSTRUCTION;
TIME FACTORS;
UNITED STATES;
|
|
EID: 0035287335
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/85559 Document Type: Note |
|
Times cited : (28)
|
|
References (0)
|
